Adrogué Horacio J, Madias Nicolaos E
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Department of Medicine, Division of Nephrology, Houston Methodist Hospital, Houston, TX, USA.
Pflugers Arch. 2024 Jun;476(6):901-909. doi: 10.1007/s00424-024-02949-6. Epub 2024 Mar 26.
Administering sodium bicarbonate (NaHCO) to patients with respiratory acidosis breathing spontaneously is contraindicated because it increases carbon dioxide load and depresses pulmonary ventilation. Nonetheless, several studies have reported salutary effects of NaHCO in patients with respiratory acidosis but the underlying mechanism remains uncertain. Considering that such reports have been ignored, we examined the ventilatory response of unanesthetized dogs with respiratory acidosis to hypertonic NaHCO infusion (1 N, 5 mmol/kg) and compared it with that of animals with normal acid-base status or one of the remaining acid-base disorders. Ventilatory response to NaHCO infusion was evaluated by examining the ensuing change in PaCO and the linear regression of the PaCO vs. pH relationship. Strikingly, PaCO failed to increase and the ΔPaCO vs. ΔpH slope was negative in respiratory acidosis, whereas PaCO increased consistently and the ΔPaCO vs. ΔpH slope was positive in the remaining study groups. These results cannot be explained by differences in buffering-induced decomposition of infused bicarbonate or baseline levels of blood pH, PaCO, and pulmonary ventilation. We propose that NaHCO infusion improved the ventilatory efficiency of animals with respiratory acidosis, i.e., it decreased their ratio of total pulmonary ventilation to carbon dioxide excretion (V/V). Such exclusive effect of NaHCO infusion in animals with respiratory acidosis might emanate from baseline increased V/V (dead space/tidal volume) caused by bronchoconstriction and likely reduced pulmonary blood flow, defects that are reversed by alkali infusion. Our observations might explain the beneficial effects of NaHCO reported in patients with acute respiratory acidosis.
对于自主呼吸的呼吸性酸中毒患者,禁忌给予碳酸氢钠(NaHCO₃),因为这会增加二氧化碳负荷并抑制肺通气。尽管如此,多项研究报告了NaHCO₃对呼吸性酸中毒患者的有益作用,但其潜在机制仍不确定。鉴于此类报告一直被忽视,我们研究了未麻醉的呼吸性酸中毒犬对高渗NaHCO₃输注(1N,5mmol/kg)的通气反应,并将其与酸碱状态正常或患有其他酸碱紊乱之一的动物进行比较。通过检查随后的动脉血二氧化碳分压(PaCO₂)变化以及PaCO₂与pH关系的线性回归来评估对NaHCO₃输注的通气反应。令人惊讶的是,在呼吸性酸中毒中,PaCO₂未能升高,且ΔPaCO₂与ΔpH斜率为负,而在其余研究组中,PaCO₂持续升高,且ΔPaCO₂与ΔpH斜率为正。这些结果无法用输注碳酸氢盐的缓冲诱导分解差异或血液pH、PaCO₂和肺通气的基线水平差异来解释。我们提出,NaHCO₃输注改善了呼吸性酸中毒动物的通气效率,即降低了它们的总肺通气与二氧化碳排泄比(V̇/V̇CO₂)。NaHCO₃输注在呼吸性酸中毒动物中的这种独特作用可能源于支气管收缩导致的基线V̇/V̇(死腔/潮气量)增加以及可能的肺血流量减少,而碱输注可逆转这些缺陷。我们的观察结果可能解释了急性呼吸性酸中毒患者中报告的NaHCO₃的有益作用。